What Medications Can Increase PSA Levels?

Medically reviewed by Mr Maneesh Ghei, Consultant Urological Surgeon (GMC: 5208045)

Several medications can affect PSA levels, either raising or lowering them artificially. 5-alpha-reductase inhibitors such as finasteride and dutasteride can reduce PSA by around 50%, potentially masking prostate cancer. Testosterone replacement therapy typically raises PSA. Statins and some anti-inflammatory drugs may also influence the result. This matters because a PSA reading taken without knowledge of your current medication can be seriously misleading. Always tell your doctor or specialist exactly what you are taking before a PSA test.

Key Takeaways

  • Several common medications raise or lower PSA, making results potentially misleading without context
  • 5-alpha-reductase inhibitors (finasteride, dutasteride) reduce PSA by up to 50% — a masked result may hide cancer
  • Testosterone replacement therapy typically raises PSA and needs to be disclosed before testing
  • Statins and some anti-inflammatories can also affect readings
  • A specialist can interpret your PSA in the context of your exact medication history

What is PSA and why does it matter?

PSA (prostate-specific antigen) is a protein produced by the prostate gland. Small amounts are present in the blood, and a PSA blood test measures these levels to screen for prostate conditions including prostate cancer, benign prostatic hyperplasia (BPH), and prostatitis.

A PSA level above 4.0 ng/mL is generally considered elevated, though age and other individual factors affect what is normal. The important thing to understand is that certain medications can push these numbers up or down significantly — which means a PSA result taken in isolation, without knowing what medications you are on, can lead to the wrong conclusion.

Related read: What Is A Dangerous PSA Level?

What medications can increase PSA levels?

Testosterone replacement therapy (TRT)

Testosterone replacement therapy is prescribed for hypogonadism and low testosterone. Because testosterone stimulates prostate tissue, TRT typically raises PSA levels. Men on TRT should have their PSA monitored regularly, as a rising PSA during treatment may indicate prostate growth or cancer development that requires further investigation.

Alpha-blockers

Alpha-blockers such as tamsulosin and doxazosin are commonly prescribed for urinary symptoms caused by BPH. Some evidence suggests alpha-blockers can modestly increase PSA in certain men, though the effect is generally small. Your specialist should be aware you are taking them when interpreting results.

Certain anti-inflammatory and herbal medications

Some non-steroidal anti-inflammatory drugs (NSAIDs) and herbal supplements, particularly those containing saw palmetto, can influence PSA levels. Saw palmetto in particular has been shown to suppress PSA similarly to 5-alpha-reductase inhibitors, which may mask elevated readings.

If you are based in London and concerned about your prostate health, Mr Maneesh Ghei consults privately at The Wellington Hospital, St John’s Wood. No GP referral is needed and same-week appointments are usually available.

Private PSA Review London

Your medication may be affecting your PSA result. Get a specialist interpretation.

Mr Ghei reviews PSA results in the context of your full medication history, age, symptoms and family risk. If your result has been influenced by medication, he can advise on the most accurate picture of your prostate health. Same-week appointments available. No GP referral required.

What medications lower PSA levels?

5-Alpha-reductase inhibitors (5-ARIs)

5-ARIs including finasteride (Proscar, Propecia) and dutasteride (Avodart) are prescribed for BPH and male pattern baldness. They work by blocking the conversion of testosterone to dihydrotestosterone (DHT), which reduces prostate size. As a side effect, they reduce PSA levels by approximately 50%.

This is clinically significant: a man on finasteride with a PSA of 2.5 ng/mL may have an actual effective level closer to 5.0 ng/mL. Doctors typically double the PSA value in men taking 5-ARIs to account for this. If this adjustment is not made, prostate cancer could be missed. According to NHS guidance on prostate cancer diagnosis, medication history is a critical factor in interpreting PSA results accurately.

Statins

Statins such as atorvastatin and simvastatin, prescribed for high cholesterol, have been shown in some studies to modestly reduce PSA levels, possibly due to their anti-inflammatory properties. The effect is generally smaller than 5-ARIs but worth noting if your PSA is being monitored over time.

Why accurate PSA interpretation matters

PSA monitoring is most valuable as a trend over time. A single elevated or suppressed result is less informative than a pattern of readings — which is why knowing what medications you were on at the time of each test is essential. Medication changes between tests can create false rises or falls that lead to unnecessary procedures or missed diagnoses.

Before any PSA test, give your doctor or specialist a complete list of everything you are taking — including prescribed medications, over-the-counter drugs and supplements.

Related read: What Not To Do Before A PSA Blood Test

Frequently Asked Questions

What medications can increase PSA levels?

Testosterone replacement therapy is the most common medication that raises PSA. Alpha-blockers and certain anti-inflammatory drugs can also modestly increase readings. Always disclose all medications to your specialist before a PSA test so results can be interpreted correctly.

Do 5-alpha-reductase inhibitors affect PSA results?

Yes — significantly. Finasteride and dutasteride reduce PSA by approximately 50%. If you are taking either of these, your doctor should double your PSA result to get an accurate picture. Failure to do this can lead to prostate cancer being missed.

Does testosterone affect PSA?

Yes. Testosterone stimulates prostate tissue and typically raises PSA levels. Men on testosterone replacement therapy need regular PSA monitoring, and any significant rise should be investigated by a specialist.

Can statins lower PSA?

Some research suggests statins can modestly reduce PSA, possibly through anti-inflammatory effects. The reduction is generally smaller than with 5-ARIs, but it is worth flagging to your doctor if you are on long-term statin therapy and having PSA monitored.

Should I stop my medication before a PSA test?

Do not stop prescribed medication without medical advice. Instead, tell your specialist exactly what you are taking. They can then interpret your result with appropriate adjustments rather than requiring you to stop a medication that may be managing another condition.

Can I get a private PSA test with a medication review?

Yes. Mr Ghei reviews PSA results in the context of your full medication history, symptoms and risk factors. He can advise whether your result is accurate, whether further investigation is needed, and what the safest next step is. No GP referral required.

Where can I see a private prostate specialist in London?

Mr Maneesh Ghei is a consultant urological surgeon with a specialist interest in prostate conditions. He sees patients privately at The Wellington Hospital, Platinum Medical Centre, St John’s Wood, London NW8 7JA. No GP referral is required and same-week appointments are available.

About the Author

Mr Maneesh Ghei, Consultant Urological Surgeon

Mr Maneesh Ghei, Consultant Urological Surgeon (GMC: 5208045)

Mr Maneesh Ghei is a consultant urological surgeon with NHS and private practice across four London hospitals. He specialises in the diagnosis and management of prostate conditions including BPH, prostatitis and prostate cancer, as well as urinary symptoms, kidney stones and male sexual health. Mr Ghei sees new patients privately with same-week availability. No GP referral is required. Book a prostate screening consultation.

Need help to book a consultation or got an enquiry regarding what tests you may need?

Fill in your details and we will contact you

🔒 Your data is secure. We’ll only use it to arrange your appointment.

Picture of Maneesh Ghei
Maneesh Ghei
Mr Maneesh Ghei MS MRCSEd MD (UCL) FRCS (Urol) is a highly experienced Consultant Urological Surgeon and founder of Urocare London, with over three decades of practice in both NHS and private settings across the capital. As Lead Cancer Clinician at Whittington Hospital, Archway, he chairs the multidisciplinary urology cancer meeting, overseeing patient care from diagnosis through to the latest minimally invasive treatments. A pioneer in complex endourology and stone disease management, Mr Ghei led the UK’s first randomised, double-blind trial of intradetrusor botulinum toxin for refractory overactive bladder. He holds an MBBS and MS in General Surgery from India, an MD from University College London, and undertook advanced fellowships in stone disease and laparoscopic surgery, culminating in his Fellowship of the Royal College of Surgeons (Urology). Committed to education and research, he supervises doctoral work in focal therapies and cryotherapy for prostate cancer and champions public awareness through annual Movember fundraising.
Scroll to Top